Frontlight ResearchEarly access
Trial site
ETG Warszawa
- 2running trials
- 4closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Alopecia areata1 trial
- Obesity1 trial
- Osteoarthritis1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Completed2 trials
- Recruiting2 trials
- Withdrawn2 trials
- Lead sponsor
- Incyte Corporation2 trials
- Enlivex Therapeutics Ltd.1 trial
- Hoffmann-La Roche1 trial
- Sun Pharmaceutical Industries, Inc.1 trial
- Zealand Pharma1 trial
Running trials
Recruiting
Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Osteoarthritis1 recruiting
- Type 1 diabetes1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities
Withdrawn
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2
Withdrawn
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
Completed
European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Site data: ClinicalTrials.govUpdated 17 Nov 2026